KF Bradstock
About
In The Last Decade
KF Bradstock
19 papers receiving 470 citations
Peers
Comparison fields: 5 of 63
- Hematology 212
- Immunology 198
- Public Health, Environmental and Occupational Health 122
- Oncology 114
- Molecular Biology 111
Countries citing papers authored by KF Bradstock
This map shows the geographic impact of KF Bradstock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KF Bradstock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KF Bradstock more than expected).
Fields of papers citing papers by KF Bradstock
This network shows the impact of papers produced by KF Bradstock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KF Bradstock. The network helps show where KF Bradstock may publish in the future.
Co-authorship network of co-authors of KF Bradstock
This figure shows the co-authorship network connecting the top 25 collaborators of KF Bradstock. A scholar is included among the top collaborators of KF Bradstock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KF Bradstock. KF Bradstock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Intensive chemotherapy in induction and consolidation for De Novo adult acute myeloid leukemia using sequential courses of high dose cytarabine, idarubicin, and etoposide: a randomized trial of the Australian leukaemia and lymphoma group (ALLG). | 2 |
| 3 | 13 | |
| 4 | 83 | |
| 5 | Effects of lenograstim (glycosylated huG-CSF) after high dose cytarabine-based induction chemotherapy for adult acute myeloid leukemia (AML) | 2 |
| 6 | 44 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 2 | |
| 10 | 9 | |
| 11 | 10 | |
| 12 | 4 | |
| 13 | 1 | |
| 14 | Intraglomerular thrombosis with deoxycoformycin--reversible acute renal failure. | 9 |
| 15 | 165 | |
| 16 | 4 | |
| 17 | 131 | |
| 18 | 28 | |
| 19 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.